For a multi-herb botanical active ingredient intended for use in veterinary oral solids, premix carriers, and injectable presentations, Jianzhu Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions is specified as a dried, milled, multi-component botanical matrix rather than a chemically pure synthetic molecule. The term “API” is used in a veterinary pharmaceutical input sense: the material is controlled by pharmacopoeial identification, drying loss, ash residue, elemental impurity, mycotoxin, microbial, and particle-size specifications. No discrete global model number is assigned by the Chinese Veterinary Pharmacopoeia; manufacturer-specific model codes vary and should be treated as commercial identifiers. A purchasing specification is more reliable when it records the applicable monograph, the intended dosage form, the extraction ratio or decoction yield, the D90 particle-size ceiling, and the terminal microbial reduction method. The native powder can be milled, blended, granulated, or encapsulated for oral solid and premix use; injectable and oral solution presentations require additional extraction, clarification, and depyrogenation because the native powder is not directly soluble or parenterally acceptable.

Specification and Release Testing for a Botanical Multi-Marker API

Release testing follows the applicable Chinese Veterinary Pharmacopoeia 2020 monograph, supplemented by supplier-specific internal limits. Identification is performed by thin-layer chromatography against botanical reference materials rather than by a single marker peak; the therapeutic effect of the formula is attributed to multiple fractions including polysaccharides, flavonoids, triterpenoid saponins, and low-concentration volatile constituents. Loss on drying is determined gravimetrically at 105°C, total ash is determined in a muffle furnace at 600°C, and acid-insoluble ash is determined after hydrochloric acid digestion. Elemental impurities are tested by ICP-MS, atomic absorption, or hydride-generation atomic fluorescence for arsenic; limits follow the general methods of the Chinese Veterinary Pharmacopoeia and regional feed-safety legislation. Microbial enumeration includes total aerobic count, total yeast and mold count, and specified pathogens. Aflatoxin screening is required because botanical raw materials may enter storage with variable drying histories and fungal load. Table 1 lists representative acceptance criteria for a dried botanical veterinary API; the applicable monograph takes precedence over illustrative values.

On production-scale classifier mills, milling rate is not determined solely by motor load. The polysaccharide fraction softens above 35°C, causing rotor coating and particle-size drift. Jacketed mill chambers and inlet air are held at 30–35°C for continuous operation; when feed moisture exceeds 8.0% w/w, throughput is derated by 20–30% to reduce screen blinding. The milled product is classified through a vibrating sieve or air classifier and oversize is recirculated. Finished particle size is reported as D10, D50, and D90 by laser diffraction; the D90 limit is tighter for premix because dispersion on a mineral carrier is sensitive to coarse botanical fragments. Low-shear blending is performed in a horizontal ribbon blender or V-blender for 15–20 min; longer blending increases electrostatic charge and fine-particle segregation. Blend uniformity is confirmed by sampling from 10 locations with a thief sampler and analyzing the marker by HPLC.

When the Powder Is Compressed Into Tablets or Filled Into Capsules

Two constraints dominate dry oral solid processing: low bulk density of the native powder and moisture sorption by the polysaccharide fraction above 60% relative humidity. Direct compression is generally not robust; dry granulation is preferred because it avoids aqueous binder exposure. If wet granulation is required, binder solution viscosity is maintained at 100–300 mPa·s to prevent overwetting and hard granule formation. Magnesium stearate is added at 0.5%–1.5% w/w after granulation and blended only until acceptable ejection force is reached; excessive lubricant blending reduces tablet tensile strength. Compression force targets a hardness of 40–80 N for immediate-release tablets, with disintegration monitored by Chinese Veterinary Pharmacopoeia or USP-compatible apparatus. Capsule filling on a dosator or tamping machine requires loss-on-drying below 5.0% w/w; higher moisture causes sticking and variable fill weight. HPMC capsules may be preferred over gelatin when storage humidity is not controlled.

Fluid-bed granulation is controlled by inlet air temperature 60–70°C and exhaust air relative humidity. The endpoint is reached when product temperature reaches 38–42°C and granule moisture falls below 5.0% w/w. Over-drying below 2.0% w/w increases granule friability and dust generation. The granulated material is sieved through an 850 µm mesh before compression; oversized granules are milled through a low-speed granulator.

For injectable presentations, direct introduction of the native powder into a sterile filter train is not permitted. The native matrix contains insoluble fibers, endotoxin, and particulate matter that would exceed parenteral limits. Injectable dosage forms are manufactured from a deproteinized aqueous extract. Hot water extraction is followed by ethanol precipitation to remove proteinaceous material and high molecular weight polysaccharides; the supernatant is clarified by depth filtration and processed by tangential flow filtration to reduce endotoxin. Pre-filtration through a 0.45 µm membrane reduces fouling before final sterile filtration through a 0.22 µm polyethersulfone membrane. pH is adjusted to 5.5–7.5 because glycosidic linkages in flavonoid glycosides hydrolyze outside this range. Depyrogenation may require a 10 kDa tangential flow filtration membrane; membrane polarization is significant, so flux and transmembrane pressure are documented at pilot scale. Published data for depyrogenation recovery of this specific formula are limited; therefore, each batch requires confirmation of filter throughput, flux decline, and pyrogen reduction according to the applicable Chinese Veterinary Pharmacopoeia 2020 method.

In oral solution manufacturing, the native powder is not directly soluble. Hot water extraction in a jacketed vessel at 90°C for 1 h dissolves water-soluble polysaccharide and flavonoid fractions; the decoction is filtered through a 200-mesh nylon cloth and then through a 10 µm polypropylene depth filter. Water-insoluble residues are discarded, so solution potency depends on extraction efficiency rather than on the weighed mass of native powder alone. The extraction ratio must be stated in the batch record. Preservative systems should avoid strongly acidic conditions below 3.5 because acidic polysaccharide fractions precipitate; alkaline conditions above 8.0 accelerate oxidative browning. The solution is buffered within the neutral to weakly acidic range and protected from ultraviolet light.

What Limits Use in Premix and Oral Solution Processing?

Premix processing is limited by carrier adhesion and segregation. The powder is pre-blended with a small mass of carrier, typically calcium carbonate or milled corncob, and then geometrically diluted into the full batch. After blending, sampling from 10 points should yield a relative standard deviation not more than 5.0%; if this limit is exceeded, mixing time is increased by 5 min increments or the carrier particle size is adjusted. The powder should be dried to loss on drying below 5.0% w/w when ambient relative humidity exceeds 60%. For oral solutions, the limiting variables are extraction temperature, extraction time, filtration area, and final pH. Extraction below 80°C reduces polysaccharide dissolution, while extraction above 95°C may degrade heat-sensitive flavonoids. The decoction is filtered immediately after extraction; cooling before filtration increases viscosity and reduces throughput. A 10 µm depth filter alone is insufficient for sterile applications; it is used only as a clarification step.

Storage stability of the dried powder depends on moisture ingress, oxidative degradation of polyphenolic constituents, and microbial recontamination. Sealed packaging with a moisture-barrier liner is required above 70% outdoor relative humidity; desiccant sachets are inserted when packages are opened in tropical climates. Storage below 25°C with protection from direct ultraviolet light is specified; ultraviolet exposure photobleaches flavonoid markers and reduces chromatographic peak area over time. Batch-to-batch botanical variation may shift the marker ratio without necessarily falling outside the pharmacopoeial acceptance range. Stability data should therefore include marker ratio, moisture, and microbial count at 0, 3, 6, 12, and 24 months under ICH-like storage conditions. If the powder is fumigated with ethylene oxide, residual gas and transformation products must be controlled according to the applicable feed or veterinary drug standard. Analytical release should be performed in an ISO/IEC 17025 accredited laboratory; non-sterile milling and blending areas should maintain ISO 14644-1 class 8 hygiene.

Comparator Products and Specification Divergence

Differences from other products are determined by the botanical matrix, degree of refinement, and regulatory intent. A single-molecule synthetic veterinary API such as a sulfonamide or tetracycline has a defined molecular mass, sharp melting point, and a single HPLC assay; Jianzhu Powder has none of these properties. A purified dry extract differs from the veterinary grade native powder because water-insoluble fibers, lipophilic components, and inorganic ash are partially removed; the purified extract may be more suitable for injectable processing but loses the full-matrix characteristics required for some traditional oral use patterns. A simple premix-grade herbal meal is not pharmaceutically controlled and may contain higher microbial loads, larger particle size, and variable botanical identity. The veterinary grade API designation therefore implies additional milling, sieving, elemental impurity testing, mycotoxin screening, and microbial enumeration. When substituting suppliers, formulators should compare extraction ratio, residual moisture, particle size distribution, heavy-metal data, and marker profile rather than assuming equivalence from the same product name.